More on LSTA

- Summary
- Chart
- Profile
- Historical

Data

- Earnings
- Ratings (5.0 Score)

Upcoming Events

- Earnings (5/11/26 *Est.)

News

- Analyst Ratings
- Earnings Related
- Guidance
- Insider Trades
- Mgmt Changes
- M & A
- Retail Sales
- Rumors
- Stock Buybacks
More...

Lisata Therapeutics (NQ:LSTA)
Delayed: 4.18 -0.05 (1.18%)
Prev. Close $4.23  
Open$4.19 
52 Wk High$ 
52 Wk Low$ 
Day High$4.19 
Day Low$4.13 
P/E N/A  
EPS$ 
Volume230,480 


Mar 6, 2026 06:15 PM Kuva Labs to acquire Lisata Therapeutics for $5 per share plus CVR
Mar 6, 2026 06:15 PM Lisata Therapeutics Enters into Definitive Agreement to be Acquired by Kuva Labs, Inc.
Feb 27, 2026 04:20 PM Form SC14D9C LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.
Feb 27, 2026 04:01 PM Form 8-K LISATA THERAPEUTICS, For: Feb 27
Jan 27, 2026 08:27 AM Form 8-K LISATA THERAPEUTICS, For: Jan 27
Jan 27, 2026 08:27 AM Form 8-K LISATA THERAPEUTICS, For: Jan 27
Jan 27, 2026 08:00 AM Lisata Therapeutics regains China rights to certepetide drug
Jan 27, 2026 08:00 AM Lisata Therapeutics Announces Mutual Termination of License Agreement with Qilu Pharmaceutical for Certepetide
Jan 21, 2026 09:28 AM Brookline Capital Markets Downgrades Lisata Therapeutics, Inc (LSTA) to Hold
Jan 21, 2026 09:20 AM Form SC14D9C LISATA THERAPEUTICS, Filed by: LISATA THERAPEUTICS, INC.
View All Articles

Entities mentioned with LSTA

View All Entities